EDGAR Filing Documents for 0000899243-17-015022

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000899243-17-015022

Filing Date

2017-06-01

Accepted

2017-06-01 19:41:24

Documents

Period of Report

2017-05-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	3475
	Complete submission text file	0000899243-17-015022.txt		5276

Mailing Address 54 RUE LA BOETIE PARIS I0 75008

Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400

Sanofi (Reporting) CIK: 0001121404 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 17886136
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142

Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200

ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations